DCM
Diag Capital Management Portfolio holdings
AUM
$87.4M
This Quarter Return
-15.25%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$87.4M
AUM Growth
–
Cap. Flow
+$87.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.17%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Baxter International
BAX
|
$5.66M |
| 2 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$5.45M |
| 3 |
Zimmer Biomet
ZBH
|
$4.95M |
| 4 |
AbbVie
ABBV
|
$4.65M |
| 5 |
Incyte
INCY
|
$4.59M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 90.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $5.66M | 6.47% | +85,933 | New | +$5.66M |
|
|
ATNX
2
DELISTED
Athenex, Inc. Common Stock
ATNX
| $5.45M | 6.23% | +429,046 | New | +$5.45M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $4.95M | 5.66% | +47,684 | New | +$4.95M |
|
|
4
AbbVie
ABBV
$372B
| $4.65M | 5.32% | +50,420 | New | +$4.65M |
|
|
5
Incyte
INCY
$16.5B
| $4.59M | 5.25% | +72,196 | New | +$4.59M |
|
6
Quanterix
QTRX
$211M
| $4.1M | 4.69% | +223,949 | New | +$4.1M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $4.05M | 4.63% | +63,159 | New | +$4.05M |
|
8
Amgen
AMGN
$155B
| $3.92M | 4.48% | +20,110 | New | +$3.92M |
|
9
Medtronic
MDT
$119B
| $3.29M | 3.76% | +36,180 | New | +$3.29M |
|
|
QTNT
10
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $3.23M | 3.69% | +526,932 | New | +$3.23M |
|
11
Takeda Pharmaceutical
TAK
$47.3B
| $2.98M | 3.41% | +177,260 | New | +$2.98M |
|
12
Abbott
ABT
$231B
| $2.79M | 3.19% | +38,585 | New | +$2.79M |
|
13
Zai Lab
ZLAB
$3.68B
| $2.79M | 3.19% | +120,092 | New | +$2.79M |
|
14
Viatris
VTRS
$12.3B
| $2.72M | 3.12% | +99,410 | New | +$2.72M |
|
|
PTE
15
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $2.47M | 2.82% | +182,833 | New | +$2.47M |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $2.41M | 2.76% | +397,375 | New | +$2.41M |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.16M | 2.47% | +5,792 | New | +$2.16M |
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| $2.15M | 2.46% | +139,531 | New | +$2.15M |
|
|
AKRX
19
DELISTED
Akorn, Inc.
AKRX
| $2.15M | 2.46% | +634,046 | New | +$2.15M |
|
20
Haemonetics
HAE
$2.63B
| $2.12M | 2.43% | +21,220 | New | +$2.12M |
|
21
argenx
ARGX
$43.6B
| $1.61M | 1.84% | +16,712 | New | +$1.61M |
|
|
BHVN
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.42M | 1.62% | +38,319 | New | +$1.42M |
|
23
Merit Medical Systems
MMSI
$5.36B
| $1.4M | 1.6% | +25,092 | New | +$1.4M |
|
24
Sanofi
SNY
$121B
| $1.31M | 1.5% | +30,240 | New | +$1.31M |
|
|
GWPH
25
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.31M | 1.5% | +13,460 | New | +$1.31M |
|